1. On August 2, 2018, the Defendant’s revocation of a medical treatment plan modification disposition against the Plaintiff.

2. The costs of lawsuit shall be.

1. Details of the disposition;

A. On November 1, 2017, while working in Company B, the Plaintiff was subject to an accident that fell from retaining wall underground to the bottom (hereinafter “instant accident”).

On November 20, 2017, the Plaintiff was diagnosed as “T-SD Hemopia, T-SAH Hemopia, cerebral cerebral surgery, cerebral cerebral cerebral typosis, thalthal typosis, thalthal thalthum, thalthalthal thalth, nOS stalthalth, thalthalthal stalth, and the left stalthalthal stalthm, etc.” due to the foregoing accident, and received the first medical care approval from the Defendant from May 2, 2018 to May 31, 2018 (30 days) and subsequently received the first medical care approval.

B. On February 5, 2018, the Defendant decided to approve all of the Plaintiff to the Evalescent hospital at D Hospital, and the Plaintiff provided medical care in Evalescent.

C. On May 21, 2018, a convalescent hospital submitted a medical treatment plan to the Defendant that it is necessary to provide medical treatment from June 1, 2018 to August 25, 2018, and the Defendant approved the above medical treatment plan to the Plaintiff on May 24, 2018.

On June 11, 2018, the E-Cvalescent submitted a medical treatment plan to the Defendant that it is necessary to provide hospitalized treatment from May 2, 2018 to August 4, 2018, and the Defendant approved the above medical treatment plan to the Plaintiff on June 27, 2018.

The written decision on approval of the above medical plan (Evidence A 3) contains the following: “The medical care was provided from May 2, 2018 to August 4, 2018 according to the result of deliberation by the advisory society on June 27, 2018, and thereafter the medical care was determined.”

E. A convalescent hospital submitted to the Defendant, on July 27, 2018, a medical treatment plan stating that it is necessary to provide hospitalized treatment from August 5, 2018 to October 31, 2018. However, the Defendant’s deliberation by the panel of advisory doctors on August 2, 2018 is reasonable.